N E W S Correction

480 NEWS Journal of the National Cancer Institute, Vol. 97, No. 7, April 6, 2005
NEWS
Correction
Due to a typesetter’s error, the
incorrect version of the third paragraph
from the end of “Tamoxifen Pharmaco-
genetics Moves Closer to Reality” (Vol.
97, No. 6, p. 412 ) was printed. The
fourth sentence should read as follows:
“He points out that the response rate for
Herceptin (trastuzumab) is only 25%,
even for patients with multiple copies of
the Her-2/neu gene.”